Boothbay Fund Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-85,618	Closed	-$1.99M	–	1586
2024 Q4	$1.99M	Sell	85,618 -6,157	-7%	-$143K	0.05%	375
2024 Q3	$2.7M	Buy	+91,775	New	+$2.7M	0.06%	349
2020 Q4	–	Sell	-423	Closed	-$75K	–	1260
2020 Q3	$75K	Buy	+423	New	+$75K	﹤0.01%	862